MELBOURNE, AUSTRALIA--(Marketwire - March 14, 2008) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced that the Company will be featured on a conference call on Friday, March 14 at 1 p.m. EDT, coordinated by Rodman & Renshaw, to discuss innovative approaches in Alzheimer’s disease therapy.
